3Bermejo-Martin JF, Andaluz-Ojeda D, Almansa R, et al.Defining immunological dysfunction in sepsis: a requisitetool for precision medicine [J]. J Infect, 2016. doi: 10. 1016/j.jinf. 2016. 01. 010.
4Ying W, Sun J, Liu D, et al. Clinical characteristics andimmunogenetics of BCGosis/BCGitis in Chinese children: a6 year follow-up study [J]. PLoS One, 2014, 9(4): e94485.
5Eyerich K, Eyerich S, Biedermann T. The multi-modalimmune pathogenesis of atopic eczema [J]. Trends Immunol,2015, 36(12): 788-801.
6Williams KW, Milner JD, Freeman AF. Eosinophilia associatedwith disorders of immune deficiency or immunedysregulation [J]. Immunol Allergy Clin North Am, 2015,35(3): 523-544.
7Farmand S, Sundin M. Hyper-IgE syndromes: recent advancesin pathogenesis, diagnostics and clinical care [J]. CurrOpin Hematol, 2015, 22(1): 12-22.
8Shah S, Wu E, Rao VK, et al. Autoimmune lymphoproliferativesyndrome: an update and review of the literature[J]. Curr Allergy Asthma Rep, 2014, 14(9): 462.
9Nakayamada S, Iwata S, Tanaka Y. Relevance of lymphocytesubsets to B cell-targeted therapy in systemic lupuserythematosus [J]. Int J Rheum Dis, 2015, 18(2):208-218.
10Sazawal S, Jalla S, Mazumder S, et al. Effect of zinc supplementationon cell-mediated immunity and lymphocyte subsetsin preschool children [J]. Indian Pediatr, 1997, 34(7):589-597.
